JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 2 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.45B |
| 3 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.34B |
| 4 |
EA
Electronic Arts
EA
|
+$903M |
| 5 |
Automatic Data Processing
ADP
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.63B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.06B |
| 3 |
Meta Platforms (Facebook)
META
|
+$942M |
| 4 |
Nike
NKE
|
+$779M |
| 5 |
Union Pacific
UNP
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.97% |
| 2 | Technology | 12.33% |
| 3 | Healthcare | 10.23% |
| 4 | Consumer Discretionary | 8.25% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
KraneShares CSI China Internet ETF
KWEB
$5.31B
| $2.54M | ﹤0.01% |
51,980
-544
| -1% | -$28.9K |
|
|
MXIM
3152
CALL
DELISTED
Maxim Integrated Products
MXIM
| $2.54M | ﹤0.01% |
+45,000
| New | +$2.71M |
|
|
ECYT
3153
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $2.54M | ﹤0.01% |
142,854
+129,556
| +974% | +$2.22M |
|
3154
CALL
CRISPR Therapeutics
CRSP
$5.22B
| $2.53M | ﹤0.01% |
57,000
+7,000
| +14% | +$367K |
|
3155
GameStop
GME
$8.33B
| $2.53M | ﹤0.01% |
662,312
-2,224,152
| -77% | -$8.53M |
|
|
ALNA
3156
DELISTED
Allena Pharmaceuticals
ALNA
| $2.53M | ﹤0.01% |
235,325
-3,885
| -2% | -$42.7K |
|
3157
CALL
Unum
UNM
$14.5B
| $2.52M | ﹤0.01% |
+64,400
| New | +$2.4M |
|
|
UBNK
3158
DELISTED
United Financial Bancorp, Inc.
UBNK
| $2.51M | ﹤0.01% |
149,023
-2,102
| -1% | -$37K |
|
|
AZUL
3159
DELISTED
Azul
AZUL
| $2.51M | ﹤0.01% |
140,875
-108,771
| -44% | -$1.92M |
|
3160
Valley National Bancorp
VLY
$8.25B
| $2.5M | ﹤0.01% |
222,647
-346,227
| -61% | -$4.18M |
|
|
EVRI
3161
DELISTED
Everi Holdings
EVRI
| $2.5M | ﹤0.01% |
272,701
+68,627
| +34% | +$563K |
|
|
ZNGA
3162
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $2.5M | ﹤0.01% |
623,434
+598,743
| +2,425% | +$2.41M |
|
3163
American Century Diversified Municipal Bond ETF
TAXF
$688M
| $2.49M | ﹤0.01% |
+50,000
| New | +$2.5M |
|
3164
Protagonist Therapeutics
PTGX
$9.8B
| $2.48M | ﹤0.01% |
240,638
+172,047
| +251% | +$1.48M |
|
|
FBC
3165
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $2.47M | ﹤0.01% |
78,582
-57
| -0.1% | -$1.9K |
|
3166
Global Net Lease
GNL
$1.9B
| $2.47M | ﹤0.01% |
118,412
-233,938
| -66% | -$4.94M |
|
|
AERI
3167
PUT
DELISTED
Aerie Pharmaceuticals
AERI
| $2.46M | ﹤0.01% |
40,000
-230,000
| -85% | -$14.8M |
|
3168
CALL
Suncor Energy
SU
$76.5B
| $2.46M | ﹤0.01% |
63,600
-38,100
| -37% | -$1.54M |
|
|
PVTL
3169
DELISTED
Pivotal Software, Inc.
PVTL
| $2.46M | ﹤0.01% |
125,370
-294,862
| -70% | -$7.19M |
|
3170
iShares US Equity Factor ETF
LRGF
$3.74B
| $2.45M | ﹤0.01% |
72,964
-1,188
| -2% | -$39.6K |
|
|
NP
3171
DELISTED
Neenah, Inc. Common Stock
NP
| $2.44M | ﹤0.01% |
28,297
-23,126
| -45% | -$2.07M |
|
3172
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
| $2.43M | ﹤0.01% |
79,071
+13,585
| +21% | +$415K |
|
|
PPL
3173
CALL
PPL Corp
PPL
$26.7B
| $2.43M | ﹤0.01% |
83,100
-8,300
| -9% | -$243K |
|
|
MYOV
3174
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.43M | ﹤0.01% |
91,595
-32,068
| -26% | -$726K |
|
3175
Constellium
CSTM
$3.95B
| $2.43M | ﹤0.01% |
196,781
+89,707
| +84% | +$1.05M |
|
Similar funds
JP Morgan Chase's Q3 2018 Portfolio in Review
As of Q3 2018, JP Morgan Chase held 6,019 positions worth $522B, up 7.4% from $486B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2018 filing shows 449 new, 2,597 increased, 2,100 reduced and 313 closed positions. Its largest new stake was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B. The largest sale was Broadcom, an estimated $1.63B.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2018 buy was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Japan ETF in Q3 2018, an estimated $1.83B increase.
- JP Morgan Chase's biggest Q3 2018 reduction was Broadcom, cutting an estimated $1.63B.
- JP Morgan Chase fully exited Cavium, Inc. in Q3 2018, selling an estimated $316M.
- JP Morgan Chase's ten largest holdings make up 18% of its $522B portfolio in Q3 2018.
- JP Morgan Chase opened 449 new positions and closed 313 in Q3 2018.
- JP Morgan Chase's portfolio value rose 7.4% quarter-over-quarter to $522B.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.